Archives: Speakers

Dr Anne Stolle

PhD in Natural Sciences

20 years in the Pharmaceutical Industry: CRO and Pharma

5 years Sales for Temp and Condition Monitoring solutions

Strong Science and Clinical Trials Background

Meets and exceeds clients expectations, consultant and solution provider

Claes Kalderén

Claes Kalderén, Chief Revenue Officer at TSS, is dedicated to evolving pharmaceutical supply chains. With 16 years’ experience in senior operational and consulting roles at multinational corporations, he drives sustainability and intelligence initiatives. Passionate about innovation, Claes aims to optimize processes and enhance efficiency. His leadership catalyzes positive change, shaping a resilient and forward-thinking industry landscape.

Allan van Konynenburg

Allan has spent the last 2 decades managing clinical trial supply management activities for the world’s key Sponsors and CRO’s, across the globe and across various study stages and therapeutic areas. A proven leader in Business Development & Operations with more than 20 years’ experience in the specialty logistics and pharmaceutical arena.

Louisa Carlse

Proven success in supporting the Health and Lifesciences industry as Partnership Director.   Fostering B2B partnerships, and driving customer success initiatives for overall efficiency across clinical trials in support of timely delivery of supplies to sites and patients. Recognized for implementing key projects, reducing compliance risks, and leading Importer of Record initiatives. Leader with a visionary and strategic mindset, fostering innovation, inclusivity, and continuous improvement.

Emily McInturf

Emily McInturf, Director of Feasibility, has worked in the clinical research industry for the past 15 years. As a leader within PSI’s global feasibility team, Emily specializes in strategy development across multiple therapeutic areas – focusing on aligning a study’s design with top enrolling investigators in the right countries.

Using PSI’s INTELIA platform, a machine-learning-powered system for data-driven feasibility and enrollment forecast, Emily models and compares hundreds of country and site combinations, their budgets and probability of success, ultimately recommending the most optimal enrollment scenario in line with each sponsor’s key objectives. As a director, Emily provides oversight for global feasibility and site identification activities for both pre- and post-award opportunities and projects.